Comments
Loading...
IGM Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:IGMS | Benzinga
IGM Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS
$-0.500
Quarterly Revenue
$499.00K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.68M
Analyze the earnings history of IGM Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IGMS | IGM Biosciences | -$0.79 | — | — | — | $1.25M | — | — | — | 08/13/2025 | Get Alert |
| IGMS | IGM Biosciences | -$0.83 | -$0.45 | -$0.50 | -11.11% | $497.00K | $4.25M | $499.00K | -88.26% | 05/13/2025 | Get Alert |
| IGMS | IGM Biosciences | -$1.01 | -$0.79 | -$0.61 | 22.78% | $651.00K | $270.00K | $412.00K | 52.59% | 03/06/2025 | Get Alert |
| IGMS | IGM Biosciences | -$1.04 | -$0.80 | -$1.01 | -26.25% | $509.00K | $270.00K | $516.00K | 91.11% | 11/08/2024 | Get Alert |
| IGMS | IGM Biosciences | -$1.43 | -$0.04 | -$0.79 | -1875.00% | $448.00K | $54.31M | $1.25M | -97.69% | 08/14/2024 | Get Alert |
| IGMS | IGM Biosciences | -$1.33 | -$0.83 | -$0.83 | 0.00% | $522.00K | $760.00K | $497.00K | -34.61% | 05/08/2024 | Get Alert |
| IGMS | IGM Biosciences | -$1.19 | -$1.03 | -$1.01 | 1.94% | $372.00K | $700.00K | $651.00K | -7.00% | 03/07/2024 | Get Alert |
| IGMS | IGM Biosciences | -$1.32 | -$1.22 | -$1.04 | 14.75% | $331.00K | $780.00K | $509.00K | -34.74% | 11/13/2023 | Get Alert |
| IGMS | IGM Biosciences | -$1.33 | -$1.43 | -$1.43 | 0.00% | $366.00K | $800.00K | $448.00K | -44.00% | 08/03/2023 | Get Alert |
| IGMS | IGM Biosciences | -$1.53 | -$1.37 | -$1.33 | 2.92% | $0.00 | $1.64M | $522.00K | -68.17% | 05/12/2023 | Get Alert |
| IGMS | IGM Biosciences | -$1.50 | -$1.25 | -$1.19 | 4.80% | $0.00 | $300.00K | $372.00K | 24.00% | 03/30/2023 | Get Alert |
| IGMS | IGM Biosciences | -$1.32 | -$1.43 | -$1.32 | 7.69% | $0.00 | $250.00K | $331.00K | 32.40% | 11/03/2022 | Get Alert |
| IGMS | IGM Biosciences | -$1.16 | -$0.94 | -$1.33 | -41.49% | $0.00 | — | $366.00K | — | 08/08/2022 | Get Alert |
| IGMS | IGM Biosciences | -$0.95 | -$1.61 | -$1.53 | 4.97% | $0.00 | — | $0.00 | — | 05/09/2022 | Get Alert |
| IGMS | IGM Biosciences | -$0.79 | -$1.54 | -$1.50 | 2.60% | $0.00 | — | $0.00 | — | 03/29/2022 | Get Alert |
| IGMS | IGM Biosciences | -$0.66 | -$1.37 | -$1.32 | 3.65% | $0.00 | — | $0.00 | — | 11/04/2021 | Get Alert |
| IGMS | IGM Biosciences | -$0.62 | -$1.17 | -$1.16 | 0.85% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| IGMS | IGM Biosciences | -$0.58 | -$0.98 | -$0.95 | 3.06% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| IGMS | IGM Biosciences | -$0.49 | -$0.87 | -$0.79 | 9.20% | $0.00 | — | $0.00 | — | 03/30/2021 | Get Alert |
| IGMS | IGM Biosciences | -$2.41 | — | -$0.66 | — | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| IGMS | IGM Biosciences | — | — | -$0.62 | — | — | — | $0.00 | — | 08/06/2020 | Get Alert |
IGM Biosciences (IGMS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-13 | $-0.50 | $-0.45 | -11.1 % |
| Q4 | 2025-03-06 | $-0.61 | $-0.79 | 22.8 % |
| Q3 | 2024-11-08 | $-1.01 | $-0.80 | -26.3 % |
| Q2 | 2024-08-14 | $-0.79 | $-0.04 | -1875.0 % |
IGM Biosciences (IGMS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-13 | $499.00K | $4.25M | -88.3 % |
| Q4 | 2025-03-06 | $412.00K | $270.00K | 52.6 % |
| Q3 | 2024-11-08 | $516.00K | $270.00K | 91.1 % |
| Q2 | 2024-08-14 | $1.25M | $54.31M | -97.7 % |
FAQ
When is IGM Biosciences (NASDAQ:IGMS) reporting earnings?
IGM Biosciences (IGMS) is scheduled to report earnings on August 13, 2025. The last reported earnings were for reported on May 13, 2025 for Q1.
What were the latest earnings per share (EPS) for IGM Biosciences (NASDAQ:IGMS)?
The Actual EPS was $-0.50, which missed the estimate of $-0.45.
What were IGM Biosciences’s (NASDAQ:IGMS) revenues?
The Actual Revenue was $499K, which missed the estimate of $4.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
